Riskpilot← Back to searchSign inGet full accessO2matic ApS
APSActiveCVR 38896636Nørrelundvej 10Manufacture of medical and dental instruments and supplies · NACE 3250Est. 201713 employees
Revenue 2024
DKK 1,5M
-279% vs 2023
EBITDA margin
-405.6%
+31% vs 2023
Equity ratio
-16.8%
Financial strength
Net profit 2024
DKK -8,3M
-2% vs 2023
| Revenue | DKK 1,5M | -279% |
| EBITDA | DKK -6,1M | +31% |
| Net profit | DKK -8,3M | -2% |
| Total assets | DKK 25,8M | +6% |
| Equity | DKK -4,3M | -210% |
| Employees | 13 | — |
Legal name
O2matic ApS
CVR number
38896636
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
29. august 2017
Share capital
DKK 610.675
Employees
13 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktøren og et bestyrelsesmedlem i forening.
Company purpose
Virksomhedens formål er udvikling, produktion og salg af medicoteknisk udstyr, software og services.
Address
Nørrelundvej 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 535 | 527 | 2.607 | 1.045 | 1.457 | -843 | 1.510 |
| Staff expenses | -325 | -190 | -782 | -1.375 | -5.067 | -5.947 | -7.635 |
| EBITDA | 210 | 337 | 1.826 | -330 | -3.610 | -8.813 | -6.125 |
| Depreciation & amort. | -0 | -234 | -310 | -311 | -311 | -738 | -1.391 |
| EBIT | 210 | 103 | 1.515 | -641 | -3.921 | -9.551 | -7.516 |
| Net financials | -1 | -4 | -9 | -15 | -171 | -680 | -1.461 |
| Profit before tax | 209 | 99 | 1.507 | -656 | -4.092 | -10.232 | -8.977 |
| Tax | 47 | 27 | 86 | -408 | -1.086 | -2.136 | -708 |
| Net profit | 163 | 72 | 1.421 | -248 | -3.006 | -8.096 | -8.269 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 5.565 | 11.882 | 17.385 | 22.489 | 28.603 | 24.264 | 25.812 |
| Equity | 3.638 | 5.894 | 7.315 | 7.067 | 12.028 | 3.935 | -4.334 |
| Long-term debt | 0 | 122 | 0 | 0 | 6.233 | 12.064 | 22.879 |
| Short-term debt | 1.341 | 4.289 | 7.852 | 12.728 | 8.100 | 8.266 | 7.267 |
| Total debt | 1.341 | 4.411 | 7.852 | 12.728 | 14.332 | 20.329 | 30.146 |
EBITDA margin
-405.6%
This company
15.8%
Market median
-2667% vs market
20182024
Equity ratio
-16.8%
This company
38.2%
Market median
-144% vs market
20182024
Return on equity
-826933500.0%
This company
18.4%
Market median
-4494203904% vs market
20182024
Net profit margin
-547.6%
This company
8.1%
Market median
-6860% vs market
20182024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20182024
Debt / equity
6.96×
This company
0.62×
Market median
-1023% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-09-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OI Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
AL Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
ML Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2025 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Danmarks Eksport- og Investeringsfond | Company | 25.0% | 25.0% | 2025 |
T&W Medical A/S | Company | 25.0% | 25.0% | 2025 |
Saber Holding ApS | Company | 20.0% | 20.0% | 2025 |
Euromed ApS | Company | 5.0% | 5.0% | 2025 |
CHRISTIAN NIELSENS FOND | Company | 5.0% | 5.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Saber Holding ApS
O2matic ApS Board members of O2matic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Okan Ilker Görgen | Chief Executive Officer | 0 companies |
| Arnt Lund | Chief Executive Officer | 0 companies |
| Marie-Louise Little | Chief Executive Officer | 0 companies |
| Farzad Saber | Deputy Chairman | 0 companies |
| Jens Dahlgaard Hove | Board of Directors | 0 companies |
| Gishok Govinthasamy | Board of Directors | 0 companies |
| Ejvind Frausing Hansen | Board of Directors | 0 companies |
| Ole Kring | Board of Directors | 0 companies |
| Lars Seier Pedersen | Board of Directors | 0 companies |
| Jacob Kildegaard Larsen | Chairman | 0 companies |
| Claudia Maria Colciago | Board of Directors | 0 companies |
| Torben Winther Kristensen | Board of Directors | 0 companies |